Identifying the Most Sensitive Patient-reported Items from the MDS-UPDRS that Predict Initiation of PD Medications in Early Disease
Objective: Objective: To determine the most sensitive combination of MDS-UPDRS Parts IB and II items that accurately predicted the clinically relevant target of dopaminergic therapy…Maintaining Isometric Contraction in Parkinson’s Disease: Effect of PD-Medication on EMG Amplitude
Objective: To quantify muscle activity changes in PD with dopaminergic medication. Background: Parkinson's disease (PD) is characterized by motor symptoms that improve with dopaminergic medication.…Incidence of orthostatic hypotension in Parkinson´s disease patients starting antiparkinsonian treatment
Objective: The main objetive of this study is to determine the percentage of patients diagnosed with Parkinson´s disease at Infanta Sofía University Hospital between september…Quercetin hinders Glial Activation to Alleviate the Cadmium Induced Dopaminergic Alteration via TNFα mediated CAMKIIα/ERK activation
Objective: The present study has therefore been carried out identify neuroprotective role of quercetin in alleviating the cadmium induced dopaminergic dysfunctions via glial mediated deactivation…Review of NPO status on admitted PD patient outcomes
Objective: To characterize the incidence and severity of outcomes for PD patients admitted to the hospital who miss doses of their medication. Background: PD is…Levodopa-induced orthostatic hypotension in parkinsonism: a red flag of autonomic failure
Objective: To evaluate the cardiovascular and hemodynamic effect of LD in patients with parkinsonism on chronic LD treatment. Background: Levodopa (LD) is the main treatment…Observations on 5 Parkinson’s patients taking Mucuna pruriens as natural source of levodopa
Objective: To explore potential benefits and tolerability of extracts from Mucuna pruriens for dopaminergic treatment of Parkinson’s patients. Background: Capsules containing freeze-dried, aqueous extract from…The effect of dopaminergic medication on force fluctuation in Parkinson’s disease
Objective: To quantify and compare muscle force variability during isometric dorsiflexion in male patients with Parkinson's Disease (PD), in the ON- versus OFF-medication state. Background:…Does the dopaminergic pathway interfere with the sustained CSF tap test effect in normal-pressure hydrocephalus?
Objective: To discuss the possible dopaminergic pathway interference as a mechanism underlying the sustained benefit of the CSF tap test in NPH. Background: The sustained…Protective approach targeting NF-kB/ Nrf2 signaling and neuroinflammation using Apigenin in LPS induced Parkinsonism in experimental rats
Objective: 1. Apigenin as a protective strategy to prevent neuroinflammation in PD.2. To find behavioral, neurochemical and histopathological changes in LPS induced PD. Background: Parkinson’s…
- 1
- 2
- 3
- …
- 5
- Next Page »